Presenter: Dr Olga Garkavenko
Title: What is Xenotransplantation and How Close Are We to Clinical Reality?
Abstract: Xenotransplantation - the use of animal cells, tissues, or organs to treat human disease - has long been considered one of medicine's most ambitious goals. Recent scientific advances have brought this field closer than ever to becoming a clinical reality.
In this session, Dr. Garkavenko explains the science behind xenotransplantation, the progress made over the past two decades, and the regulatory, ethical, and biological challenges that must still be overcome. Discover how this emerging technology could help address the global shortage of donor organs and reshape the future of transplantation medicine.
Date:
This Scientific & Technological Advances workshop will run on Thursday 13th August from 10:00 am - 12:00 pm and include a tea / coffee break.
About the expert
Dr Olga Garkavenko
Dr. Garkavenko holds PhD in Biochemistry, Oncology and has been actively involved in ground breaking cell therapy and xenotransplantation in New Zealand for more than 25 years. Currently she is a Chief Scientific Officer in NZeno ltd based in Auckland, New Zealand. Dr. Garkavenko is an expert in xenotransplantation, cell biology and microbiological safety regulatory affair.
Other learning activities you may be interested in

Society & Us Workshop (Culture & Connection)

Creative Arts Workshop (Lessons from the Improv Stage for Everyday Life)

Society & Us Workshop (Environmental Justice in Aotearoa)

Creative Arts Workshop (Shakespeare: The Ultimate Screenwriter Debate)

Creative Arts Workshop (Creativity After Corporate Life)

Technological Impact Workshop (Evolution of the Internet and Digitisation)

Creative Arts Workshop (Inside Medicine: Filmmaking Behind the Scenes)

Technological Impact Workshop (Navigating Innovation in Payments and Identity)

Creative Arts Workshop (The Business of Show)

Technological Impact Workshop (How Technology Is Becoming More Human)

Technological Impact - Single Session (Nature First AI)

